Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Endocr Relat Cancer. 2015 Apr;22(2):L1–L4. doi: 10.1530/ERC-14-0429

Table 1.

Logistic Regression Analysis of Risk of Adenoma for Serum Levels of RBP4

Including DM Pts.§
Excluding DM Pts.
β ± SE OR* 95% C.I. p β ± SE OR* 95% C.I. p
Base model** 0.32 ± 0.15 3.1 1.15 – 8.66 0.03 0.32 ± 0.16 3.13 0.01 – 9.49 0.04
Full model 0.32 ± 0.15 3.1 1.11 – 8.97 0.03 0.32 ± 0.16 3.13 1.004 – 9.84 0.04
Full model +HOMA 0.32 ± 0.16 3.1 1.04 – 8.97 0.04 0.29 ± 0.17 2.82 0.87 – 8.84 0.09
*

ORs for each 35 µg/mL (approximately 1 standard deviation) increment of RBP4.

**

Base model adjusts for age, race and gender.

Full model adjusts for age, race, gender, BMI (body mass index), non-steroidal anti-inflammatory drug use (6 months or longer), known family history and smoking (pack years).

33 missing values in HOMA-IR index.

§

diabetes treatment status is included in the three models as a covariate.